{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["112(2)"],"submitter":["Paine H"],"pubmed_abstract":["<h4>Background</h4>Long-term symptom burden and health-related quality-of-life outcomes after curative oesophageal cancer treatment are poorly understood. Existing tools are cumbersome and do not address the post-treatment population specifically. The aim of this study was to validate the six-symptom LASORS tool for identifying patients after curative oesophageal cancer treatment with poor health-related quality of life and to assess its clinical utility.<h4>Methods</h4>Between 2015 and 2019, patients from 15 UK centres who underwent curative-intent oesophageal cancer treatment, and were disease-free at least 1 year after surgery, were invited to participate in the study and complete LASORS and European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-OG25 questionnaires. "],"journal":["The British journal of surgery"],"pagination":["znae319"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11843645"],"repository":["biostudies-literature"],"pubmed_title":["LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study."],"pmcid":["PMC11843645"],"pubmed_authors":["Vohra RS","Abbassi-Ghadi N","Maynard N","Behrens P","Mohammadi B","Qureshi Y","Paine H","Awad S","Johar A","Preston SR","Griffiths EA","Underwood T","Markar SR","Gossage J","Dai N","Hanna GB","Lagergren P","O'Neill JR","Alkhaffaf B","Chidambaram S","Singh P","Jones R","Dawas K"],"additional_accession":[]},"is_claimable":false,"name":"LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study.","description":"<h4>Background</h4>Long-term symptom burden and health-related quality-of-life outcomes after curative oesophageal cancer treatment are poorly understood. Existing tools are cumbersome and do not address the post-treatment population specifically. The aim of this study was to validate the six-symptom LASORS tool for identifying patients after curative oesophageal cancer treatment with poor health-related quality of life and to assess its clinical utility.<h4>Methods</h4>Between 2015 and 2019, patients from 15 UK centres who underwent curative-intent oesophageal cancer treatment, and were disease-free at least 1 year after surgery, were invited to participate in the study and complete LASORS and European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-OG25 questionnaires. ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2025-07-03T03:04:34.945Z","creation":"2025-04-03T23:56:44.813Z"},"accession":"S-EPMC11843645","cross_references":{"pubmed":["39982378"],"doi":["10.1093/bjs/znae319"]}}